Pharma Management (Cayman) Ltd.
New York, NY · 5 funds and programs
Fund sponsor
Pharma Management (Cayman) Ltd. of New York, NY is named on SEC Form D filings for 5 private funds and programs since 2015, most recently on Feb 10, 2020. Together they report $682M raised from 136 investor positions.
- Funds and programs
- 5Filed on Form D
- Total raised
- $682MCumulative sales reported on Form D, all funds
- Investor positions
- 136Summed across funds; one investor may be in several
- First fund
- Apr 2015Earliest first sale or filing
- Latest Form D
- Feb 10, 2020Most recent filing by any of its funds
- Latest fund's offering
- Rule 506(b)No general advertising
Private investment funds (5)
Fund
First sale
Raised
Investors
Minimum
Offering
RPI US Partners 2019, LP
New York, NY
First sale—
Raised$0
Investors0
MinimumNone set
Offering506(b)
RPI International Holdings 2019, LP
New York, NY
First sale—
Raised$0
Investors0
MinimumNone set
Offering506(b)
RPS BioPharma Holdings, LP
George Town, Cayman IslandsOffshore
First saleMar 2017
Raised$150M
Investors21
Minimum$100K
Offering506(b)
RPS BioPharma Investments, LP
George Town, Cayman IslandsOffshore
First saleMar 2017
Raised$164M
Investors57
Minimum$100K
Offering506(b)
RPI International Holdings, LP
New York, NY
First saleApr 2015
Raised$368M
Investors58
MinimumNone set
Offering506(b)
Grouped by AltMountain from the company named on each Form D and the funds' names, so the list may be incomplete or include a related fund. New programs are added automatically when they file. Request a correction
From SEC filings, not verified. This page summarizes Form D filings as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the sponsor or its funds. “Raised” is cumulative sales, not current assets or performance. Full disclosures